title: Treatment of chronic hepatitis B with lamivudine in renal allograft recipients.
authors.affiliation: Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
authors.forename: D
authors.initials: D
authors.lastname: Lewandowska
authors.forename: M
authors.initials: M
authors.lastname: Durlik
authors.forename: K
authors.initials: K
authors.lastname: Kukuła
authors.forename: T
authors.initials: T
authors.lastname: Cieciura
authors.forename: R
authors.initials: R
authors.lastname: Ciecierski
authors.forename: B
authors.initials: B
authors.lastname: Walewska-Zielecka
authors.forename: J
authors.initials: J
authors.lastname: Szmidt
authors.forename: W
authors.initials: W
authors.lastname: Rowiński
authors.forename: M
authors.initials: M
authors.lastname: Lao
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016030:Kidney Transplantation; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D019259:Lamivudine